Choose a partner who has developed and manufactured assays like yours, can tell you plainly what is most likely to go wrong, has real experience with your regulatory pathway, can carry the program past advice if you need it, and will say when not to proceed.
Choosing an in vitro diagnostic (IVD) consulting partner is itself a high-stakes decision. The right partner can save a diagnostic program months and a great deal of money.
The wrong one can give confident advice that sends a program down an expensive dead end. This guide covers what to look for, what to ask, and the warning signs that should give a technical buyer pause, drawn from how experienced diagnostic teams actually evaluate the partners they work with.
Why Partner Selection Matters More Than Most Buyers Expect
Diagnostics is a field where bad advice is hard to detect until it is expensive. A consultant who recommends the wrong assay format, underestimates a regulatory pathway, or overlooks clinical performance requirements can leave a program looking healthy right up until the moment it fails. By then the cost is not just the consulting fee. It is the months of development built on a flawed foundation.
That is why partner selection in this market deserves more scrutiny than IVD manufacturers and diagnostic companies often give it. You are not buying hours of advice. You are buying into the judgment that your program will be built on, and that judgment is hard to evaluate from a website.
What IVD Consultants Are (and Aren’t) Responsible For
Before evaluating partners, it helps to be clear about scope. A consultant is responsible for guidance, assessment, and expertise: identifying risks, recommending approaches, supporting risk management, and helping you make informed decisions. A consultant is not, by default, responsible for executing the development work or manufacturing the product, unless the engagement explicitly extends that far.
Two boundaries are worth stating plainly. The manufacturer, not the consultant, always remains the legally responsible party for the medical device. And no credible partner will guarantee a specific clearance or approval, because regulatory agencies and notified bodies act independently. A partner who is candid about both is more trustworthy than one who implies otherwise.
This is where the line between a standalone consultancy and an integrated CDMO matters. A pure advisory firm hands you a recommendation and steps away, and does so without any financial stake in which manufacturer you eventually choose. That vendor-agnostic position is a genuine advantage if you already have a manufacturing partner in place or plan to select one independently.
A CDMO that also consults can carry that same understanding directly into development and production, which for programs that do not yet have a manufacturing home removes an entire category of handoff risk.
Neither model is automatically better, but they are different purchases, and you should know which one you are making. For a fuller explanation of where consulting fits in a diagnostic program, see our overview of what IVD consulting covers.
Five Questions to Ask to Choose the Right Consulting Partner
- Have you actually developed and manufactured assays like mine? Direct, hands-on experience with your assay type matters more than general industry tenure. Ask for specifics about format and application, not just years in the field.
- What do you think is most likely to go wrong with my program? A strong partner will already have an instinct for your risks and will tell you plainly. A weak one will deflect or stay vague.
- What is your regulatory affairs experience with my intended pathway? CLIA waiver, FDA 510(k) submission, and IVDR each carry different demands. Confirm the partner has relevant experience with yours, rather than general regulatory experience.
- Can you support the program beyond advice if I need it? Even if you only want consulting now, knowing whether the partner can carry into development or manufacturing later tells you how much continuity is available if the program grows.
- What would make you tell me not to proceed? The answer reveals honesty. A partner who can articulate the conditions under which they would advise against a project is one who will tell you the truth when it matters.
Red Flags in IVD Consulting Engagements
- Generic, buzzword-heavy language. Talk of innovation and breakthroughs without concrete technical detail usually signals shallow expertise.
- Reluctance to discuss limitations. A partner who never says a target is hard or a timeline is tight is selling, not advising.
- No real development or manufacturing track record. Advice from people who have only ever advised carries less weight than advice from people who have shipped product.
- The purely regulatory advisor. A partner who knows the text of the regulations but has never worked at a bench, in a laboratory, or on a manufacturing floor will often design a regulatory strategy that looks correct on paper but cannot be executed by the people who actually have to build the assay.
- One-size-fits-all recommendations. If the advice sounds the same regardless of your specific assay, it probably is.
- Vague scope and deliverables. If you cannot tell exactly what you will get from the engagement, that ambiguity tends to favor the consultant rather than you.
Integrated Consulting vs. Standalone Consulting: The Continuity Advantage
The single biggest structural difference among IVD consulting partners is their ability to execute. A standalone consultancy advises and stops. An integrated CDMO can advise, then develop, then manufacture, all with the same team that built the original understanding of your program.
| Standalone consultancy | Integrated CDMO | |
|---|---|---|
| What you get | Advice and recommendations, then the engagement ends | Advice, then development and manufacturing with the same team |
| Handoffs | Each move to a developer or manufacturer is a handoff | The same team carries context across stages |
| Vendor position | No stake in which manufacturer you choose | Can carry the program into development and production |
| Best fit | You already have a manufacturing partner or plan to select one independently | You do not yet have a manufacturing home |
That continuity matters because diagnostics programs lose enormous value at handoffs. Every time a program moves from one organization to another, from advisor to developer, from developer to manufacturer, context is lost, and risk goes up. The failure mode buyers fear most, an assay that works in development but falls apart during manufacturing scale-up, is very often a handoff failure in disguise.
A partner who can carry your program across those boundaries without a handoff removes an entire category of risk. This is the model Palladium operates under: consulting, lateral flow assay development, and contract manufacturing under one team, so that guidance can become a product without losing what was learned along the way.
Frequently Asked Questions
What credentials should an In Vitro Diagnostic consultant have?
Look less at titles and more at demonstrated, hands-on experience developing and manufacturing diagnostics like yours. Relevant technical track record and honest references matter more than generic industry tenure.
Should my consulting partner also be able to manufacture a medical device?
Not necessarily, but it is a significant advantage. A partner that can carry a program from consulting into development and manufacturing removes the technology-transfer risk that comes with stitching together separate vendors.
What are the common mistakes to avoid when hiring an IVD consulting partner?
The most common mistakes are about timing, experience matching, and contract terms.
- Starting the engagement too late. The most valuable consulting input happens during early product development, before assay architecture, reagent selection, and regulatory pathway are locked in. Bringing in a partner after those decisions have been made limits what they can actually change in your program.
- Over-weighting regulatory credentials over development experience. A consultant who can navigate regulatory requirements and produce accurate technical documentation but has never developed or manufactured an assay will offer advice that looks right on paper but often fails at the bench. In the diagnostics industry, the gap between knowing what the regulations require and knowing how to build a product that meets them is where most programs quietly go wrong.
- Confusing general experience with pathway-specific experience. General medtech or diagnostics experience is not a substitute for specific knowledge of your intended submission pathway. Analytical performance requirements, performance studies, and clinical evidence thresholds differ significantly between a CLIA waiver, an FDA 510(k) submission, and IVDR compliance. The right question is not whether a partner knows the IVD space, but whether they know your specific regulatory requirements.
- Choosing on fee without accounting for continuity. If a consulting partner cannot carry a program into development or manufacturing, the technology-transfer cost when the program changes hands often exceeds whatever was saved on consulting fees. The right partner for the full product lifecycle is worth more than the lowest-cost advisor for a single phase.
- Leaving scope and deliverables undefined. Vague agreements favor the consultant. A well-defined engagement specifies exactly what you will receive, when, and what success looks like. The right consulting partner will welcome that clarity, not resist it.
How do I evaluate a consultant’s regulatory experience?
Ask specifically about your intended pathway, whether CLIA waiver, FDA 510(k) submission, or IVDR, rather than regulatory experience in the abstract. Each pathway has distinct compliance requirements, and relevant experience is what counts.
What does a first consulting engagement typically involve?
Usually a structured assessment of where your program stands, the risks that matter most, and a prioritized set of next steps. A good first engagement leaves you with clarity and an action plan, including on post-market obligations down the road, whether or not you continue with that partner.
Choose a Partner Who Can Go the Distance
The best IVD consulting partner is one whose advice you can trust and whose team, when you need it, can build what they recommend. If you are evaluating partners for a diagnostic program, learn more about Palladium Diagnostics IVD consulting services or start a conversation with our team.
